UCAR Logo

UCAR

ALUCR | PA

Overview

Corporate Details

ISIN(s):
FR0011070457
LEI:
969500K8EPT7JBE7FP45
Country:
France
Address:
10 RUE LOUIS PASTEUR, 92100 BOULOGNE-BILLANCOURT
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

The University Corporation for Atmospheric Research (UCAR) is a nonprofit consortium of over 100 member universities and colleges focused on research and training in atmospheric and Earth system sciences. Its primary role is managing the National Science Foundation National Center for Atmospheric Research (NSF NCAR), a federally funded research and development center. UCAR provides the scientific community with access to advanced research facilities, observing and computing resources, data services, and educational programs. The organization fosters collaboration between academia, government, and the private sector to accelerate scientific discovery in geosciences.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for UCAR. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2022-07-08 16:50
Delisting Announcement
COMMUNIQUE RELATIF A LA MISE EN ŒUVRE DU RETRAIT OBLIGATOIRE VISANT LES ACTIONS…
French 162.7 KB
2022-07-07 10:16
Major Shareholding Notification
Franchissement de seuils
French 201.7 KB
2022-07-05 15:13
Declaration of Voting Results & Voting Rights Announcements
UCAR - Nombre d'actions et de droits de vote au 30 06 2022
French 183.0 KB
2022-06-22 09:02
M&A Activity
MISE A DISPOSITION DE LA NOTE D’INFORMATION EN REPONSE ET DU DOCUMENT « AUTRES …
French 200.2 KB
2022-06-22 09:00
M&A Activity
MISE A DISPOSITION DE LA NOTE D’INFORMATION ET DES INFORMATIONS RELATIVES AUX C…
French 121.8 KB
2022-06-02 09:18
Declaration of Voting Results & Voting Rights Announcements
UCAR - Nombre d'actions et de droits de vote au 31 mai 2022
French 182.3 KB
2022-05-25 16:50
Pre-Annual General Meeting Information
COMMUNIQUE RELATIF AU DEPOT D’UN PROJET DE NOTE EN REPONSE AU PROJET D’OFFRE PU…
French 516.9 KB
2022-05-23 17:50
M&A Activity
UCAR - Accord avec FRANCE PARE BRISE
French 314.5 KB
2022-05-23 10:52
Declaration of Voting Results & Voting Rights Announcements
Franchissement de seuils
French 201.9 KB
2022-05-23 10:50
Major Shareholding Notification
Franchissement de seuils
French 199.0 KB
2022-05-17 19:00
M&A Activity
UCAR - Réalisation de l’acquisition par GOA LCD d’un bloc de contrôle au capita…
French 221.9 KB
2022-05-11 14:55
Declaration of Voting Results & Voting Rights Announcements
UCAR - Nombre d'actions et de droits de vote au 30 avril 2022
French 180.7 KB
2022-04-11 15:30
M&A Activity
UCAR – rapprochement avec le Groupe Cosmobilis – Projet d’OPAS visant les actio…
French 348.7 KB
2022-04-08 09:00
Delisting Announcement
UCAR - Suspension de cours
French 170.0 KB
2022-04-07 21:05
Earnings Release
UCAR - Résultats 2021
French 227.0 KB

Automate Your Workflow. Get a real-time feed of all UCAR filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for UCAR via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
PILA PHARMA AB Logo
Clinical-stage biopharma developing a first-in-class oral drug for diabetes and obesity.
Sweden PILA
Plantarc Bio Ltd. Logo
Agritech firm using gene discovery & editing to improve crop yield, resilience, and pest control.
Israel PLNT
POLAREAN IMAGING PLC Logo United States of America POLX
Poltreg S.A. Logo
Develops T-regulatory cell (Treg) therapies for autoimmune diseases like diabetes and MS.
Poland PTG
POOLBEG PHARMA PLC Logo
AI-led biopharma developing drugs for high-need diseases like CRS and metabolic disorders.
United Kingdom POLB
Poxel Logo
Biopharma developing treatments for metabolic diseases like NASH, with a marketed drug for diabetes.
France POXEL
PROTEOME SCIENCES PLC Logo
CRO providing proteomics services & TMT® tags to biopharma for drug discovery & biomarkers.
United Kingdom PRM
PROVEXIS PLC Logo
Develops & licenses Fruitflow®, a patented ingredient for heart health in food & supplements.
United Kingdom PXS
Psych Capital Plc Logo
Develops psilocybin-based therapies for anorexia nervosa and other mental health conditions.
United Kingdom PSY
Pure Biologics S.A. Logo
Develops novel antibody and aptamer drugs for immuno-oncology and autoimmunity.
Poland PUR